In an interview with David Hutton of Ophthalmology Times, Ash Abbey, MD, discusses the Phase 3 LUGANO trial for EYP-1901 in treating wet age-related macular degeneration. Abbey discusses the trial’s ...
Robert T. Chang, MD, from Stanford University discusses how large language models are transforming ophthalmology by enhancing ...
A group of German researchers has discovered how tiny eye movements and the density of photoreceptors assist in visual acuity ...
Researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases
Rensselaer researchers receive $6.4 million grant from NEI to seek new treatment for blindness-causing diseases.
The investigators explained that AMN, a rare disease, is characterized by dark reddish, wedge-shaped macular lesions. 2 Impairment of the retinal deep capillary plexus also occurs and suggests ...
Dropless cataract surgery eliminates postoperative eye drops, enhancing patient adherence and reducing complications like ...
Chronic therapy is essential for PCV patients, even after resolution of pigment epithelial detachment, to prevent recurrence.
Observations show distinct variations between the changes in optic nerve head (ONH) and the macula.
Joanne F. Shen, MD, director of the dry eye clinic at Mayo Clinic's campus in Phoenix, Arizona, and a research team studied ...
Jibran Sharieff, MD, and Brandon Kingrey, MD, discuss their innovative smartphone-based device for affordable retinal imaging ...
In this case report, Gad and colleagues performed corneal confocal microscopy to assess for evidence of nerve regeneration ...
200 mg of caffeine elevated the blood pressure after 2 hours but did not impact the retinal VD.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback